119 related articles for article (PubMed ID: 35274596)
21. Early versus late salvage abdominoperineal resection for anal squamous cell carcinoma: Is there a difference in survival?
Fields AC; Melnitchouk N; Senturk J; Irani J; Bleday R; Goldberg J
J Surg Oncol; 2019 Aug; 120(2):287-293. PubMed ID: 31055841
[TBL] [Abstract][Full Text] [Related]
22. [A Case of Squamous Cell Cancer of the Anus Treated with Chemoradiotherapy].
Takeuchi T; Inoue A; Nishizawa Y; Kagawa Y; Aomatsu M; Tsuji Y; Hirano M; Komatsu H; Tomokuni A; Miyazaki Y; Motoori M; Fushimi H; Iwase K; Gotoh M; Fujitani K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2133-2135. PubMed ID: 35045516
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
[TBL] [Abstract][Full Text] [Related]
24. [Anal squamous cell carcinoma-a report of 6 cases].
Yonaiyama S; Koyama M; Tsutsumi S; Morohashi H; Sakamoto Y; Murata A; Hakamada K; Hatayama Y; Kawaguchi H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2116-8. PubMed ID: 22202301
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China.
Yuan Y; Xie WH; Li RZ; Chang H; Zeng ZF; Gao YH; Wang QX; Xiao WW
Cancer Med; 2022 Jan; 11(1):117-127. PubMed ID: 34816622
[TBL] [Abstract][Full Text] [Related]
26. [Diagnosis and Therapy of Anal Carcinoma].
Radke A; Beyer J
Praxis (Bern 1994); 2022 Feb; 110(2):89-96. PubMed ID: 35105214
[TBL] [Abstract][Full Text] [Related]
27. Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines.
Leon O; Guren M; Hagberg O; Glimelius B; Dahl O; Havsteen H; Naucler G; Svensson C; Tveit KM; Jakobsen A; Pfeiffer P; Wanderås E; Ekman T; Lindh B; Balteskard L; Frykholm G; Johnsson A
Radiother Oncol; 2014 Dec; 113(3):352-8. PubMed ID: 25499203
[TBL] [Abstract][Full Text] [Related]
28. Extended-Field Chemoradiation Therapy for Definitive Treatment of Anal Canal Squamous Cell Carcinoma Involving the Para-Aortic Lymph Nodes.
Holliday EB; Lester SC; Harmsen WS; Eng C; Haddock MG; Krishnan S; Das P; Hallemeier CL
Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):102-108. PubMed ID: 29907489
[TBL] [Abstract][Full Text] [Related]
29. Review of anal cancer patients at the Ottawa hospital.
Abunassar M; Reinders J; Jonker DJ; Asmis T
Eur J Surg Oncol; 2015 May; 41(5):653-8. PubMed ID: 25776438
[TBL] [Abstract][Full Text] [Related]
30. Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.
Oliveira SC; Moniz CM; Riechelmann R; Alex AK; Braghirolli MI; Bariani G; Nahas C; Hoff PM
J Gastrointest Cancer; 2016 Mar; 47(1):75-81. PubMed ID: 26691173
[TBL] [Abstract][Full Text] [Related]
31. Anal cancer chemoradiotherapy outcome prediction using
Rusten E; Rekstad BL; Undseth C; Klotz D; Hernes E; Guren MG; Malinen E
Br J Radiol; 2019 May; 92(1097):20181006. PubMed ID: 30810343
[TBL] [Abstract][Full Text] [Related]
32. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.
Glynne-Jones R; Nilsson PJ; Aschele C; Goh V; Peiffert D; Cervantes A; Arnold D; ; ;
Eur J Surg Oncol; 2014 Oct; 40(10):1165-76. PubMed ID: 25239441
[TBL] [Abstract][Full Text] [Related]
33. Definitive Chemoradiotherapy for Anal Carcinoma: Long-Term Results Based on Consistent Time-to-Event Endpoints.
De Felice F; Martinetti MT; Orelli S; Bulzonetti N; Musio D; Tombolini V
Oncology; 2018; 94(1):25-30. PubMed ID: 28918425
[TBL] [Abstract][Full Text] [Related]
34. The Swedish National Care Programme for Anal Carcinoma--implementation and overall results.
Friberg B; Svensson C; Goldman S; Glimelius B
Acta Oncol; 1998; 37(1):25-32. PubMed ID: 9572651
[TBL] [Abstract][Full Text] [Related]
35. Surgery Is an Effective Option after Failure of Chemoradiation in Cancers of the Anal Canal and Anal Margin.
Delhorme JB; Severac F; Waissi W; Romain B; Antoni D; Freel KC; Schumacher C; Rohr S; Brigand C; Noël G
Oncology; 2017; 93(3):183-190. PubMed ID: 28571009
[TBL] [Abstract][Full Text] [Related]
36. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
[TBL] [Abstract][Full Text] [Related]
37. Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma.
El-Hadaad HA; Wahba HA; Roshdy S
J Gastrointest Cancer; 2015 Jun; 46(2):156-60. PubMed ID: 25810165
[TBL] [Abstract][Full Text] [Related]
38. Squamous Cancers of the Rectum Demonstrate Poorer Survival and Increased Need for Salvage Surgery Compared With Squamous Cancers of the Anus.
Kulaylat AS; Hollenbeak CS; Stewart DB
Dis Colon Rectum; 2017 Sep; 60(9):922-927. PubMed ID: 28796730
[TBL] [Abstract][Full Text] [Related]
39. Inguinal Lymph Node Dissection Does Not Improve Overall Survival in Anal Cancer Nodal Disease.
Lin ACH; Hakim A; Kellish AS; Singh P; Wozniak M; Kwiatt M; Gaughan J; Hong YK
J Surg Res; 2020 Nov; 255():13-22. PubMed ID: 32540576
[TBL] [Abstract][Full Text] [Related]
40. [Restatment. Anal Cancer].
Vendrely V
Rev Prat; 2021 Sep; 71(7):759-763. PubMed ID: 34792915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]